Insider Transactions in Q1 2025 at Adverum Biotechnologies, Inc. (ADVM)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
85,068
+3.16%
|
$340,272
$4.6 P/Share
|
|
Feb 27
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
86,802
+3.33%
|
$347,208
$4.46 P/Share
|
|
Feb 26
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
164,886
+6.35%
|
$659,544
$4.01 P/Share
|
|
Feb 25
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,125
+29.6%
|
-
|
|
Feb 25
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+20.56%
|
-
|
|
Feb 25
2025
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,125
+35.61%
|
-
|
|
Feb 25
2025
|
Rabia Gurses Ozden Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,125
+50.0%
|
-
|
|
Feb 25
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
13,125
+23.76%
|
-
|